Gene Editing News
Eli Lilly to buy gene-editing biotech Verve Therapeutics Inc. for $1.3 billion

Published 391 days ago
Nobel Prize-winning gene editing tech offers a ray of hope for blood disorders

Published 943 days ago
Subscribe Now! Get features like


